Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors

Por Luo, Min, Fu, Li-Wu
Publicado no Am J Cancer Res (2014)

Roles for Sildenafil in Enhancing Drug Sensitivity in Cancer

Por Shi, Zhi, Tiwari, Amit K, Patel, Atish S., Fu, Li-Wu, Chen, Zhe-Sheng
Publicado em 2011

ABCG2-overexpressing S1-M1-80 cell xenografts in nude mice keep original biochemistry and cell biological properties

Por Wang, Fang, Liang, Yong-Ju, Wu, Xing-Ping, Su, Xiao-Dong, Fu, Li-Wu
Publicado em 2012

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer

Por To, Kenneth K.W., Poon, Daniel C., Wei, Yuming, Wang, Fang, Lin, Ge, Fu, Li-wu
Publicado no Data Brief (2016)

P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells

Por Wu, Qiu-Liang, Wu, Xing-Ping, Liang, Yong-Ju, Chen, Li-Ming, Ding, Yan, Fu, Li-Wu
Publicado no World J Gastroenterol (2005)

Lapatinib Antagonizes Multidrug Resistance–Associated Protein 1–Mediated Multidrug Resistance by Inhibiting Its Transport Function

Por Ma, Shao-lin, Hu, Ya-peng, Wang, Fang, Huang, Zhen-cong, Chen, Yi-fan, Wang, Xiao-kun, Fu, Li-wu
Publicado em 2014

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro

Por Yan, Yan-Yan, Wang, Fang, Zhao, Xiao-Qin, Wang, Xiao-Kun, Chen, Yi-Fan, Liu, Hong, Xie, Yong, Fu, Li-Wu
Publicado no Oncol Rep (2017)

Bullatacin Triggered ABCB1-Overexpressing Cell Apoptosis via the Mitochondrial-Dependent Pathway

Por Liang, Yong-Ju, Zhang, Xu, Dai, Chun-Ling, Zhang, Jian-Ye, Yan, Yan-Yan, Zeng, Mu-Sheng, Chen, Li-Ming, Fu, Li-Wu
Publicado em 2009

Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)

Por DENG, WEN, DAI, CHUN-LING, CHEN, JUN-JIANG, KATHAWALA, RISHIL J., SUN, YUE-LI, CHEN, HAI-FAN, FU, LI-WU, CHEN, ZHE-SHENG
Publicado em 2013

Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Inducing Cell Apoptosis

Por Li, Guang-quan, Chen, Xing-gui, Wu, Xing-ping, Xie, Jing-dun, Liang, Yong-ju, Zhao, Xiao-qin, Chen, Wei-qiang, Fu, Li-wu
Publicado em 2012

Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo

Por Wang, Xiao-kun, Kin Wah To, Kenneth, Huang, Li-yan, Xu, Jing-hong, Yang, Ke, Wang, Fang, Huang, Zhen-cong, Ye, Sheng, Fu, Li-wu
Publicado no Oncotarget (2014)

Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes

Por Dai, ChunLing, Ma, ShaoLin, Wang, Fang, Zhao, HongYun, Wu, XingPing, Huang, ZhenCong, Chen, ZheSheng, To, Kenneth, Fu, LiWu
Publicado no Oncotarget (2015)

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Por Liang, Shao-Bo, Teng, Jian-Jian, Hu, Xue-Feng, Yang, Xing-Li, Luo, Min, Fang, Xiao-Na, Liu, Dong-Sheng, Chen, Yong, Fu, Li-Wu
Publicado no BMC Cancer (2017)

Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China

Por Liang, Shao-Bo, Wang, Yan, Hu, Xue-Feng, He, Sha-Sha, Yang, Xing-Li, Liu, Li-Zhi, Cui, Chun-Yan, Chen, Yong, Fu, Li-Wu
Publicado no J Cancer (2017)

Lapatinib and erlotinib are potent reversal agents for MRP7(ABCC10)-mediated multidrug resistance

Por Kuang, Ye-Hong, Shen, Tong, Chen, Xiang, Sodani, Kamlesh, Hopper-Borge, Elizabeth, Tiwari, Amit Kumar, Lee, Jeferson W K K, Fu, Li-Wu, Chen, Zhe-Sheng
Publicado em 2009

Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein

Por Zhou, Wen-jing, Zhang, Xu, Cheng, Chao, Wang, Fang, Wang, Xiao-kun, Liang, Yong-ju, To, Kenneth Kin Wah, Zhou, Wang, Huang, Hong-bing, Fu, Li-wu
Publicado em 2012

Axitinib Targeted Cancer Stemlike Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibiting the Drug Transport Function of ABCG2

Por Wang, Fang, Mi, Yan-jun, Chen, Xing-Gui, Wu, Xing-ping, Liu, Zhenguo, Chen, Shu-peng, Liang, Yong-ju, Cheng, Chao, To, Kenneth Kin Wah, Fu, Li-wu
Publicado em 2012

The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance

Por Shi, Zhi, Parmar, Smitaben, Peng, Xing-Xiang, Shen, Tong, Robey, Robert W., Bates, Susan E., Fu, Li-Wu, Shao, Yining, Chen, Yang-Min, Zang, Feiyang, Chen, Zhe-Sheng
Publicado em 2009

WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells

Por Zhang, Hui, Zhang, Yun-Kai, Wang, Yi-Jun, Kathawala, Rishil J, Patel, Atish, Zhu, Hua, Sodani, Kamlesh, Talele, Tanaji T, Ambudkar, Suresh V, Chen, Zhe-Sheng, Fu, Li-Wu
Publicado no Cancer Sci (2014)

In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1

Por Zhang, Hui, Patel, Atish, Ma, Shao-Lin, Li, Xiao Jie, Zhang, Yun-Kai, Yang, Pei-Qi, Kathawala, Rishil J, Wang, Yi-Jun, Anreddy, Nagaraju, Fu, Li-Wu, Chen, Zhe-Sheng
Publicado no Br J Pharmacol (2014)